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Abstract 14 
 15 
Metabolism of protein by gut bacteria is potentially detrimental due to production of toxic 16 
metabolites, such as ammonia, amines, p-cresol, and indole. Consumption of prebiotic 17 
carbohydrates produces specific changes in the composition and/or activity of the microbiota 18 
that may confer benefits upon host wellbeing and health. Here, we have studied the impact of 19 
prebiotics on proteolysis within the gut in vitro.  20 
Anaerobic stirred batch cultures were inoculated with omnivore (n=3) and vegetarian (n=3) 21 
faeces. Four protein sources (casein, meat, mycoprotein and soy protein) with and without 22 
supplementation by a oligofructose enriched-inulin. Bacterial counts, and concentrations of 23 
short chain fatty acids (SCFA), ammonia, phenol, indole, and p-cresol were monitored during 24 
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fermentation. Addition of the fructan prebiotic Synergy1 increased levels of bifidobacteria (p= 25 
0.000019 and 0.000013 for omnivores and vegetarians respectively). Branched chain fatty 26 
acids (BCFA) were significantly lower in fermenters with vegetarians’ faeces (p=0.004), 27 
reduced further by prebiotic treatment. Ammonia production was lower with Synergy1. 28 
Bacterial adaptation to different dietary protein sources was observed through different patterns 29 
of ammonia production between vegetarians and omnivores. In volunteer samples with high 30 
baseline levels of phenol, indole, p-cresol and skatole, Synergy1 fermentation led to a reduction 31 
of these compounds.  32 
 33 
Importance: Dietary protein intake is high in Western populations which could result in 34 
potentially harmful metabolites in the gut from proteolysis. In an in vitro fermentation model, 35 
addition of prebiotics reduced the negative consequences of high protein levels. 36 
Supplementation with a prebiotic resulted in a reduction of proteolytic metabolites in the model. 37 
A difference was seen in protein fermentation between omnivore and vegetarian gut 38 
microbiotas: bacteria from vegetarian donors grew more on soy and QuornTM, than on meat 39 
and casein with reduced ammonia production. Bacteria from vegetarian donors produced less 40 
BCFA.  41 
Introduction 42 
 43 
Dietary protein levels in western European populations can be as high as 105g/d according to 44 
the Food and Agriculture Organization (1). However, the recommended dietary allowance 45 
(RDA) is 56g/d for men and 46g/d for women (2). This may result in high residual colonic 46 
nitrogen, with dietary protein having escaped digestion in the upper intestine entering the large 47 
gut where it can become a substrate for the colonic microbiota. Approximately 16g of protein 48 
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will be present in the colon following ingestion of 105g protein/day of which 8g are 49 
endogenous and 8g are exogenous (3, 4). Among the endogenous proteins, there are 69.2% 50 
bacterial proteins, 16.9% mucin, 7.65% enzymes, and 6.2% mucosal cells (5, 6).  51 
 52 
Anaerobic metabolism of carbohydrate by gut bacteria produces short chain fatty acids 53 
(SCFA), and gases from different pathways. Production of SCFA, mainly acetate, propionate, 54 
and butyrate, in the lumen is generally believed to mediate health benefits such as maintaining 55 
colonic epithelial cell function, regulate energy intake and satiety, controlling inflammation, 56 
and defend pathogen invasion (7). Microbial breakdown of protein not only generates SCFA 57 
and gases, however, but also ammonia, amines, indolic and phenolic compounds, and branched 58 
chain fatty acids (BCFA) through the deamination and decarboxylation of amino acids (8). 59 
Though evidence on humans is scarce, in studies in rats and in ex vivo studies, ammonia at a 60 
physiologically relevant dose can harm colon barrier function, shorten colonocyte lifespan, and 61 
is co-carcinogenic in rats (9-11). Hydrogen sulphide can be produced from sulphur containing 62 
amino acids and is toxic to colonocytes, damaging DNA and blocking utilisation of butyrate as 63 
an energy source (12-15). Metabolism of tyrosine, phenylalanine and tryptophan produces 64 
phenol, indole, p-cresol and skatole which are potential carcinogens; phenol and p-cresol can 65 
reduce intestinal epithelial barrier function in vitro (10, 16, 17). BCFAs are generated from 66 
branched chain amino acids such as valine, leucine, and iso-leucine which make them 67 
biomarkers for bacterial proteolysis, however there are no human physiological roles for 68 
BCFAs known (18).  69 
 70 
Thus, foods entering the colon can have a health impact on the host, possibly by changing gut 71 
microbiota composition and activity. The International Agency for Research on Cancer (19), 72 
an agency under the World Health Organization (WHO) published a press release in October 73 
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2015: where it classified red meat as “probably carcinogenic to humans”, and processed meat 74 
as “carcinogenic to humans”, with concerns over colorectal cancer (19). Some epidemiological 75 
studies found reduced risk of colorectal cancer (CRC) with high consumption of dietary fibre, 76 
while red meat and processed meat had a positive correlation with CRC (20-23). Animal 77 
protein intake was associated with increased inflammatory bowel disease (IBD) risk in two 78 
Japanese and French studies (24, 25).  79 
 80 
Increased consumption of prebiotics, which can reach the colon resulting in specific changes 81 
in the composition and/or activity in the gastrointestinal microflora, may counter the negative 82 
effects of gut microbial proteolysis in persons ingesting high protein diets (26). Inulin-type 83 
fructans can resist hydrolytic enzymes in the human GI tract and are resistant to small intestinal 84 
absorption, subsequently they become a substrate source for the microbiota within the large 85 
intestine. The impact of inulin on the gut microbiome has been studied using in vitro and in 86 
vivo approaches (27-29). The aim of this study was to understand metabolism of gut bacteria 87 
proteolysis in the distal colon and how prebiotics can affect the proteolysis, therefore, to 88 
investigate the potential of consuming prebiotics to counteract the negative effect of having 89 
high protein diet.  90 
Results 91 
Bacterial Enumeration 92 
 93 
Total bacteria and most microbial groups that were monitored in this study reached the highest 94 
number after 24 hours incubation. However lactobacilli, Faecalibacterium prausnitzii and 95 
Roseburia numbers only increased in the first 10 hours with lactobacilli numbers in particular 96 
declining after 10 hours. Bacterial populations from omnivores and vegetarians responded 97 
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differently to the proteins: faecal bacteria from omnivores had insignificant higher counts on 98 
meat and casein than on soy protein and QuornTM extract, while faecal bacteria from 99 
vegetarians had higher counts on soy protein and QuornTM extract (8.75±0.40 log10 CFU/ml) 100 
than meat and casein (8.38±0.47 log10 CFU/ml) (p=0.03).  101 
The vegetarian microbiota had higher bifidobacteria and lactobacilli counts at the beginning 102 
compared to omnivore microbiota (Supplementary Tables 1 and 2).  103 
 104 
In order to investigate proteolytic bacteria, independent t tests were performed to compare 105 
samples with protein addition (casein, meat, mycoprotein and soy protein) and controls at 24 106 
and 48 hours (Figure 1 and 2). Though there are studies confirming that many Bacteroides. 107 
spp., are proteolytic (30), we found no significant changes in Bacteroides. spp. on protein 108 
substrates. Clostridium coccoides, Eubacterium rectale and Clostridium cluster XIVa and 109 
XIVb grew on protein substrates: bacteria from omnivore donors had higher counts comparing 110 
to the control group (p=0.055) while those from vegetarian donors were significantly higher 111 
(p<0.01). Roseburia number did not change with protein added. Atopobium cluster from both 112 
omnivore and vegetarian donors grew on protein substrates with statistical significance. 113 
Clostridial cluster IX populations in cultures inoculated with samples from vegetarian donors 114 
increased on the protein substrates significantly, while cultures with omnivore samples were 115 
not statistically different. Lower counts of clostridial cluster IX in vegetarian donors’ controls 116 
could explain the difference. Desulfovibrio counts were significantly higher with protein from 117 
both omnivore and vegetarian donors. Clostridium clusters I and II also grew more on proteins 118 
however, growth only reached statistical significance with inocula from vegetarians.  119 
 120 
To investigate how prebiotics may modify the microbiota, independent t tests were used to 121 
compare cultures with prebiotics and without, after 24 and 48 hours fermentation (Figure 1 and 122 
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2). Synergy1 addition significantly boosted the growth of total bacteria, bacteroides, clostridial 123 
cluster IX, bifidobacteria, and lactobacilli with both omnivore and vegetarian inocula, with 124 
bifidobacteria displaying the highest growth on Synergy1. In cultures with vegetarian donor’ 125 
samples, Clostridium coccoides, Eubacterium rectale and Clostridium cluster XIVa and XIVb, 126 
Roseburia, Faecalibacterium prausnitzii, and Atopobium also had significant higher count with 127 
prebiotics than without. There were no inhibitory effects of prebiotics found on any of bacterial 128 
groups monitored in this study. 129 
Organic Acids 130 
 131 
Most organic acids accumulated during fermentation and reached their highest concentrations 132 
at 24 or 48 hours fermentation, with the exception of lactate which transiently increased during 133 
the first 10 hours then gradually decreased to below 1mM at 48 hours. Branched amino acids 134 
such as leucine and isoleucine can be metabolised by faecal bacteria to produce BCFA 135 
indicating proteolytic fermentation. Omnivores had higher BCFA production (4.03±5.25mM) 136 
while vegetarians had little production (1.61±1.60mM) (p=0.004). For instance, while growing 137 
on casein, bacteria from omnivores produced 10.19±8.62 and 13.13±10.93 mM of isobutyrate 138 
and isovalerate respectively, while bacteria from vegetarians produced 2.03±2.16 and 139 
3.52±3.29 mM of isobutyrate and isovalerate (Supplementary Table 1 and 2).  140 
Comparing samples with protein and without at 24 and 48 hours, cultures inoculated with both 141 
omnivore and vegetarian donors had significantly higher concentrations of acetate, propionate, 142 
isobutyrate, butyrate, and isovalerate on protein (Figure 3 and 4). However, fermentation 143 
samples with prebiotics had significantly elevated concentration of acetate and succinate at 24 144 
and 48 hours, and significantly more lactate at 6 and 10 hours (Figure 3 and 5). 145 
 146 
Butyric acid production was low in this study and no changes were found in cultures with 147 
7 
 
omnivores samples; this correlates with the lack of differences in populations of butyrate-148 
producing bacteria (Roseburia and Faecalibacterium prausnitzii). In samples with vegetarian 149 
donors’ inocula, butyrate producers (Clostridium coccoides, Eubacterium rectale and 150 
Clostridium cluster XIVa and XIVb, Roseburia, Faecalibacterium prausnitzii) had 151 
significantly higher counts, however, butyrate production was not significantly increased.  152 
Concentrations of BCFA were lower on prebiotics although without statistical significance. 153 
Variation in BCFA production between donors was seen in this study, therefore, two-way 154 
ANOVA on isovalerate and isobutyrate was used to examine the effect of both treatment and 155 
donor on production. A significant influence of donor on isobutyrate and isovalerate was found 156 
with six donors (p<0.01). Donor variation may indicate that a larger sample size is needed to 157 
observe the inhibitory effect of prebiotics on BCFA production. (Supplementary Table 3)  158 
Volatile Organic Compounds 159 
 160 
This study quantified four potentially detrimental volatile organic compounds (VOCs) which 161 
were indole, phenol, p-cresol and skatole. Production of these compounds varied with 162 
individual donor and the effect of prebiotics on VOCs production also varied according to 163 
donor diet. Production of VOCs, from highest to lowest, was indole, phenol, p-cresol and 164 
skatole in most cases. However, with soy protein, phenol production was higher than indole 165 
production. With all donors, comparing negative and positive controls, the production of 166 
volatile compounds was reduced by Synergy1. However, comparing cultures on 167 
protein+Synergy1 with cultures on the corresponding protein, production of indole, phenol, p-168 
cresol and skatole were inhibited by Synergy1 after 48 hours fermentation with inocula from 169 
omnivore donor 1, omnivore donor 2 and vegetarian donor 1. These three donors produced 170 
relatively high levels of phenol and indole on protein(292.20±521.76 µg/ml) compared with 171 
others (28.92±23.61 µg/ml) (p=0.02). Fermentation models inoculated with these high VOCs 172 
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producers, Synergy1+protein models produced significantly less phenol and indole 173 
(113.21±227.94 µg/ml) (p=0.046).  174 
Protein source affected production of VOCs. According to this study, casein resulted in the 175 
highest concentration of VOCs in five donors, this was probably because casein is high in 176 
aromatic amino acids which are the main substrates for bacteria to produce phenolic and indolic 177 
compounds. Omnivore donor 3 had low phenolic production from casein correlating with this 178 
donor’s low total bacterial count (Supplementary Table 4). 179 
Ammonia  180 
 181 
Ammonia is a major metabolite of protein fermentation by faecal bacteria. Ammonia 182 
concentrations increased gradually during fermentation on all substrates together with the 183 
negative control when compared to the positive control. Ammonia concentrations on Synergy1, 184 
however, remained at low levels (17.55±4.53mM at 48 hours for omnivores and 185 
25.47±4.55mM for vegetarians) compared to all protein treatments in this study. The volunteer 186 
diet also influenced the selective fermentation of faecal substrates. With faecal samples from 187 
omnivores, fermentation resulted in higher ammonia levels on casein and meat extract, 188 
however, with faecal samples from vegetarians, soy protein and Quorn extract produced more 189 
ammonia (Figure 6). 190 
 191 
Fermentation on protein for 24 hours resulted in significantly higher concentrations of 192 
ammonia compared to fermentation without protein using both omnivore and vegetarian 193 
samples (p<0.001). Fermentation on prebiotics resulted in significantly lower concentrations 194 
of ammonia in cultures with omnivore donors’ faecal bacteria (Table 1).  195 
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Discussion 196 
Lactate production peaked at 10hours fermentation while other organic acids concentrations 197 
kept increasing. This coincided with counts of lactobacilli and was to be expected as lactate 198 
can be utilised by several bacteria to produce other SCFAs. Changes in propionic acid 199 
producing Bacteroides and Clostridium cluster IX populations were seen and propionic acid 200 
increased in vessels containing Synergy1 with the difference reaching significance with 201 
omnivore donors’ samples (p=0.006). Succinate is an intermediate product for propionate 202 
production, the succinate pathway being widely present in bacteroides (31). The significantly 203 
higher levels of succinate in samples with Synergy1 could be associated with propionate 204 
production by bacteroides. 205 
 206 
Faecal bacteria responded differently on various substrates in pH controlled stirred batch 207 
cultures. Total bacteria number from vegetarians were significantly more on soy protein and 208 
QuornTM than meat and casein. Host dietary habits may explain a preference for different 209 
protein sources. Growth of proteolytic bacteria from the human gut supported this: Clostridium 210 
coccoides and Eubacterium rectale from omnivore microbiota and vegetarian microbiota grew 211 
on meat/casein and soy/QuornTM respectively (Supplementary Tables 1 and 2). Ammonia 212 
concentrations also indicate that an omnivore microbiota and a vegetarian microbiota favour 213 
different protein sources based on their host diet. A possible reason is differences in amino acid 214 
composition among various proteins: bacteria that have adapted to the host diet can breakdown 215 
peptides, metabolise amino acids or utilise coupled Stickland amino acid fermentation.  216 
By observing fermentation characteristics of the negative controls: saccharolytic 217 
bifidobacterial growth at 6 hours with omnivore faeces occurred, indicating that there was a 218 
small amount of undigested saccharides within the omnivore faecal sample. However, this was 219 
not seen from the vegetarian donors.  220 
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Even when total bacteria tend to be more saccharolytic, there were some proteolytic bacteria 221 
present in the gut microbiota. The genus Clostridium contains more than 100 species and these 222 
bacteria can be saccharolytic, proteolytic, or both. Within clostridial clusters I and II, there are 223 
saccharolytic species such as C. butyricum and C. beijerinckii; C. sporogenes and C. 224 
acetobutylicum are both saccharolytic and proteolytic; there are proteolytic species such as C. 225 
limosum and C. histolyticum (32). This might explain why Clostridium spp. grew on prebiotics 226 
with a vegetarian microbiota: saccharolytic types from this genus were likely to be stimulated 227 
by prebiotics. This would also imply that these faecal bacteria from vegetarians are more 228 
saccharolytic than clostridia from omnivore donors.  229 
 230 
Vegetarian donor 1 had the highest production of phenolic and indolic compounds together 231 
with the highest E. coli population which correlate with the ability of E. coli to produce 232 
phenolic compounds (33). Indole and p-cresol are conjugated as indoxyl sulphate and p-cresol 233 
sulphate in the human body; before they are excreted via urine, they are toxic to human 234 
endothelial cells, can reflect the progression of chronic kidney diseases, and increase 235 
cardiovascular disease risk for such patients (34-37).  Therefore, reduced production of indole 236 
and p-cresol can benefit human health in many ways.  237 
 238 
Studies feeding rats with different protein sources did not find higher colonic toxicity of casein 239 
comparing with soybean, which is contrary to the phenol and p-cresol results in this study (38, 240 
39). Feeding red meat gave higher DNA damage than feeding casein in rats (40). Similar effects 241 
were found in human epidemiological research: dairy products were inversely correlated with 242 
colorectal cancer in Finnish men and New York University women; they speculated that this 243 
protective effect may result from other nutrients in the dairy products but not from 244 
macronutrients such as protein (41, 42). Mycoprotein is a relatively new protein source from 245 
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the filamentous fungus Fusarium venenatumsource under the trade mark of QuornTM  (43). 246 
QuornTM products contain all the essential amino acids, are low in fat and high in dietary fibre. 247 
However, in terms of protein fermentation by gut microbiota, QuornTM was no different to other 248 
proteins.  249 
The use of pH controlled stirred batch culture systems allowed rapid analysis of different 250 
protein fermentations by gut microbiota and the impact of prebiotics. This fermentation system 251 
is limited however: SCFAs would be absorbed from the human colon and the digesta supply 252 
would be continuous. 253 
 254 
Some animal studies and human studies have revealed an inhibitory effect of proteolysis by 255 
prebiotics such as resistant starch, FOS, and XOS (44-49). These were investigated by 256 
analysing indolic/phenolic compounds, or nitrogen secretion in the urine and faeces. One of 257 
these studies also compared DNA damage with and without resistant starch in rat colonic cells, 258 
and found that the starch protected cells from DNA damage (46). One possible mechanism of 259 
decreased proteolytic fermentation in the presence of prebiotics is through the enhanced growth 260 
of saccharolytic bacteria requiring more amino acids for growth, reducing amino acid 261 
availability for proteolytic bacteria.  262 
 263 
Differences between the gut microbiotas from vegetarian and omnivore donors are not clear 264 
with three donors, however, fermentation patterns on different substrates were seen in this study 265 
such as the differences in BCFA, ammonia, and total bacteria. In terms of protein fermentation 266 
by faecal bacteria, based on the different ammonia production and bacteria growth response to 267 
different protein source: microbiota from vegetarian donors have adapted to vegetarian protein 268 
sources and can utilise these proteins more efficiently. In addition, in this study, lower BCFA 269 
production was found with vegetarians’ gut bacteria; this could suggest that these donors had 270 
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lower branched chain amino acids in their diet. Prebiotic supplementation lowered proteolytic 271 
metabolites more in cultures with omnivores’ samples comparing to cultures with vegetarians’ 272 
bacteria: vegetarian donors are more likely to be on a high fibre diet and may need a higher 273 
dose of Synergy1 to see a prebiotic effect (50).  274 
 275 
Addition of Synergy1 at the beginning to 48 hour batch culture fermentation changed the 276 
microbiota to a more saccharolytic nature by stimulation of bifidobacteria and lactobacilli 277 
without a significant change of Clostridium and E. coli. Supplementation with Synergy1 also 278 
reduced the concentration of protein metabolites (ammonia with significance and BCFA but 279 
not reaching significance); in those donors with high production of VOCs, inhibition was also 280 
found with Synergy1. An inulin rich diet could be beneficial in individuals with high protein 281 
diet, however, this effective dose of inulin is relatively difficult to achieve, especially in people 282 
consuming a Western diet (51, 52). Therefore, adding fructan prebiotics could potentially 283 
reduce the negative consequences of ingesting high protein diets, although this would need to 284 
be demonstrated in vivo. EFSA have approved the use of chicory inulin at a dosage of 12g per 285 
day to maintain normal bowel function, however, the effective does of prebiotics to regulate 286 
bacterial proteolysis is unknown (53). In this study, 5g of inulin type fructans were effective in 287 
vitro, but production of metabolites such as phenol and indole was only inhibited in some of 288 
the donors. This needs to be validated in vivo and a higher dose might have a better inhibitory 289 
effect and cover more of the population. This study also revealed the importance of host 290 
habitual diet on the metabolic function of human gut microbiome. This infers that host diet 291 
shapes the gut bacteria in a profound way. The individual difference is significant which again 292 
could due to individual diet difference.  293 
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Materials 294 
Proteins 295 
Protein substrates used were casein hydrolysate (Sigma-Aldrich, Poole, UK, meat extract for 296 
microbiology (Sigma-Aldrich, Poole, UK), soy protein acid hydrolysate powder (Sigma-297 
Aldrich, Poole, UK), and mycoprotein which was extracted from a commercial product 298 
(QuornTM) purchased from a local supermarket.  299 
Prebiotic 300 
Inulin-type fructan was a mixture of oligofructose and inulin: 50%±10% DP (degree of 301 
polymerisation) 3-9 and 50%±10% DP≥10 (Orafti®Synergy 1, BENEO-Orafti, Tienen, 302 
Belgium).  303 
Methods 304 
Protein extraction 305 
Mycoproteins were extracted from QuornTM based on the method described by R. J. H. 306 
Williams et al. (54). QuornTM mince (500g) was mixed with 1200ml water and then 307 
homogenised in a blender. 60ml of formic acid was added after homogenisation and the pH 308 
lowered to 1.6. Afterwards, 5g pepsin was added and the solution incubated at 37°C for 48 309 
hours. Samples were centrifuged at 3000g for 15 minutes and the supernatants freeze-dried for 310 
later use. After extraction, the nitrogen content of mycoproteins was quantified using the 311 
Kjeldahl method (Campden BRI, UK) and was found to be 10.3%. The remaining mycoprotein 312 
was stored at -20°C. 313 
Protein dose determination 314 
Based on previous validation work from in vitro batch culture experiments and in human trials, 315 
the dose of 1% of substrate (w/v) equates to 5g inulin reaching the colon (27, 55). Synergy1 316 
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(1% w/v) was used in this study to investigate the prebiotic effect. The approach used in a 317 
150ml batch culture experiments to simulate high protein ingestion is shown in Table 2. The 318 
amount of casein, meat extract, mycoprotein and soy protein was adjusted based on their true 319 
protein content which is shown in Table 3.  320 
 321 
In vitro batch culture fermentation 322 
 323 
Faecal Sample Preparation 324 
Ethical approval of collecting faecal samples from healthy volunteers was obtained from 325 
University of Reading University Research Ethics Committee in 2014. Faecal samples were 326 
obtained from three healthy meat eating individuals and three healthy vegetarian volunteers 327 
between the ages of 18 and 60 (vegetarians 34.44±6.03 years old and omnivores 29.33±3.06) 328 
who had not taken antibiotics for at least six months prior to the experiment and had no history 329 
of gastrointestinal disorders. None were taking prebiotic supplements. All volunteers were 330 
following their diet for at least 5 years.  331 
Faecal samples were diluted 1 in 10 (w/v) using 1M, pH7.4, anaerobically prepared phosphate 332 
buffered saline (PBS, Oxoid, Hampshire, UK). This solution was homogenised in a stomacher 333 
(Seward, stomacher 80, Biomaster) for 120 seconds at normal speed. 15mL of this was then 334 
immediately used to inoculate batch culture vessels. 335 
Batch Culture Basal Nutrient Medium. 336 
 337 
Basal nutrient medium was prepared with chemicals obtained from Sigma-Aldrich, Poole, UK 338 
unless otherwise stated. In one litre: 2g peptone water, 2g yeast extract (Oxoid, Hampshire, 339 
UK), 0.1g NaCl, 0.04g K2HPO4 (BDH, Poole, UK), 0.04g KH2PO4 (BDH), 0.01g 340 
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MgSO3.7H2O (Fischer scientific, Loughborough, UK), 0.01g CaCl2.6H2O, 2g NaHCO3 341 
(Fischer), 0.5g L–cystine HCl, 2mL Tween 80, 10µL vitamin K1, 0.05g haemin, 0.05g bile 342 
salts (Oxoid), 4ml resazurin (pH7).  343 
 344 
pH controlled, stirred batch culture fermentation 345 
 346 
Vessels with an operating volume of 300mL were set up. 135mL of basal nutrient medium was 347 
autoclaved (121°C for 15 minutes) and aseptically poured into sterile vessels.  This system was 348 
left overnight with oxygen free nitrogen sparging into the medium at a rate of 15mL/min. After 349 
4 hours of fermentation, nitrogen flow was stopped and gas outlets were clamped to trap gas. 350 
pH meters (Electrolab pH controller, Tewksbury, UK) were connected to each vessel to regulate 351 
pH 6.7 to 6.9 with the aid of 0.5M HCl or NaOH.  352 
 353 
Each vessel was also temperature controlled at 37°C and stirred using a magnetic stirrer. 354 
Prebiotic and relative protein treatment were added to the vessels prior to inoculation with 355 
15mL of faecal inoculum. For each donor, 10 vessels were prepared for 10 treatments: casein, 356 
meat extract, Quorn, soy protein, casein+Synergy1, meat extract+Synergy1, Quorn+Synergy1, 357 
soy protein+Synergy1, Synergy1, and a negative control.  358 
 359 
Samples were removed from the fermenters after 0, 6, 10, 24 and 48 hours incubation.  360 
Enumeration of faecal microbial populations by flow cytometry fluorescence in situ 361 
hybridisation (FISH) 362 
 363 
A 750µl sample of batch culture fluid was centrifuged at 11337 × g for 5 minutes and the 364 
supernatant discarded. The pellet was then suspended in 375µl filtered 0.1M PBS solution. 365 
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Filtered cold (4°C) 4% paraformaldehyde (PFA) (1125µl) was added and samples were stored 366 
at 4°C for 4 hours. These were then washed thoroughly with PBS to remove PFA and re-367 
suspended in a mixture containing 300 µl PBS and 300 µl 99% ethanol. Samples were then 368 
stored at -20°C prior to FISH analysis by flow cytometry. Filtered cold (4°C) 0.1M PBS (500 369 
µl) was mixed with fixed samples (75µl), before centrifuged at 11337 × g for 3 minutes. The 370 
pellets were then resuspended in 100µl of TE-FISH (Tris/HCl 1 M pH 8, EDTA 0.5 M pH 8, 371 
and filtered distilled water with the ratio of 1:1:8) containing lysozyme solution (1 mg/ml of 372 
50,000 U/mg protein). Samples were then incubated in the dark at the room temperature for 373 
10 minutes, and then centrifuged at 11337 × g for 3 minutes. Pellets were washed with 500µl 374 
filtered cold PBS, and then washed with 150µl hybridisation buffer (5 M NaCl, 1 M Tris/HCl 375 
pH 8, formamide, ddH2O, 10% SDS with the ratio of 180:20:300:499:1) and centrifuged at 376 
11337 × g for 3 minutes. Pellets were then resuspended in 1ml of hybridisation buffer. 377 
Aliquots (50µl) with 4µl of different probes (50 ng l1) were incubated at 35°C for at least 378 
10 hours. The probes used in this study are listed in Table 7. Non Eub, Eub338-I-II-III are 379 
attached with fluorescence Alexa488 at the 5´ end, and other specific probes are attached with 380 
Alexa647. A set of Non Eub, Eub338-I-II-III are attached with fluorescence Alexa647 at the 381 
5´ end to be the controls. For samples to detect specific groups, 4µl of Eub338-I-II-III were 382 
added together with 4µl specific probes. Hybridisation buffer (150µl) was added to each 383 
aliquot after incubation, followed by 3 minutes centrifugation at 11337 × g. Supernatants 384 
(150µl) were carefully removed before samples were centrifuged at 11337 × g for 3 minutes. 385 
Remaining supernatant was then removed, and pellets were resuspended in 200µl washing 386 
buffer. Washing buffer was prepared as: 12.8µl of 5M Na Cl, 20µl of 1M Tris/HCl pH 8, 10µl 387 
of 0.5 M EDTA pH 8, and 1µl of 10 % SDS in 956.2µl of filtered cold distilled water. 388 
Samples were then incubated at 37°C for 20 minutes and centrifuged at 11337 × g for 3 389 
minutes. After supernatant removal, pellets were resuspended in different volume of filtered 390 
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cold PBS based on flow cytometry load. Bacteria counts were then calculated with the 391 
consideration of flow cytometry reading and PBS dilution. 392 
Short chain fatty acid (SCFA) analysis by gas chromatography 393 
Samples were centrifuged at 11337 × g for 10 minutes to remove all particulate matter. 394 
Supernatants were then filtered through a 0.2 µm polycarbonate syringe filter (VWR, 395 
Farlington, UK). Extraction was done with some modifications of a method from A. J. 396 
Richardson et al. (69). Filtered sample (500µl) was transferred into a labelled 100 mm×16 mm 397 
glass tube (International Scientific Supplies Ltd, Bradford, England) with 25 μl of 2-398 
ethylbutyric acid (0.1 M, internal standard) (Sigma, Poole, UK). Concentrated HCl (250µl) and 399 
1 ml diethyl ether were added to each glass tube and samples vortexed for 1 minute. Samples 400 
were then centrifuged at 2000 × g for 10 minutes. The diethyl ether (upper) layer of each sample 401 
was transferred to a labelled clean glass tube. A second extraction was conducted by adding 402 
another 0.5 ml diethyl ether, followed by vortexing and centrifugation. The diethyl ether layers 403 
were pooled. Pooled ether extract (400µl) and 50 μl N-(tert-butyldimethylsilyl)-N-404 
methyltrifluoroacetamide (MTBSTFA) (Sigma-Aldrich, Poole, UK) were added into a GC 405 
screw-cap vial. Samples were left at room temperature for 72 hours to allow lactic acid in the 406 
samples to completely derivatise. 407 
 408 
An Agilent/HP 6890 Gas Chromatograph (Hewlett Packard, UK) using an HP-5MS 409 
30m×0.25mm column with a 0.25μm coating (Crosslinked (5%-phenyl)-methylpolysiloxane, 410 
Hewlett Packard, UK) was used for analysis of SCFA. Temperatures of injector and detector 411 
were 275°C, with the column programmed from 63°C for 0 minutes to 190°C at 15°C min-1 412 
and held at 190°C for 3 minutes. Helium was the carrier gas (flow rate 1.7 ml min-1; head 413 
pressure 133 KPa). A split ratio of 100:1 was used.  Quantification of the samples was obtained 414 
through calibration curves of lactic acid and acetic, propionic, butyric, valeric and branched 415 
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SCFA (iso-butyric and iso-valeric) in concentrations between 12.5 and 100 mM.  416 
 417 
Volatile organic compounds analysis by GC-MS 418 
Entrapment of volatile compounds 419 
 420 
All fermentation samples were adjusted to a pH of 7.0 ± 0.3 using hydrochloric acid or sodium 421 
chloride prior to volatile entrapment. Each sample (1 g) was placed in a 250mL conical flask 422 
fitted with a Dreschel head. The flask was placed in a water bath maintained at a temperature 423 
of 30°C for 1 hour. The flask was attached to oxygen-free nitrogen (40mL/min) which swept 424 
volatile compounds from the headspace above the sample onto a glass trap (4 mm i.d., 6.35 425 
mm o.d. x 90 mm long), containing 85mg of Tenax TA poly (a porous polymer absorbent based 426 
on 2,6-diphenylene-oxide) (Supelco, Poole, UK). Following volatile extraction, 1µL of 1, 2 427 
dichlorobenzene in methanol (653ng/µL) was added to each trap as an internal standard and 428 
the trap was then flushed with oxygen free nitrogen to remove moisture (100mL/min) for 10 429 
minutes.  430 
Gas Chromatography and Mass spectrometry (GC-MS) 431 
 432 
Volatile compounds collected on the Tenax adsorbent were analysed using a Perkin-Elmer 433 
Claris 500 GC-MS, attached to an automated thermal desorber (Turbomatrix ATD, Perkin 434 
Elmer, Beaconsfield, UK).  Tenax traps were desorbed at 300°C for 10 min and the volatiles 435 
cryofocused on the internal cold trap held at -30°C. After desorption, the cold trap was heated 436 
to 300 °C at 40°C per second to release volatile material onto the GC column. GC separation 437 
was carried out on a DB-5 non-polar column (60m x 0.32mm id, 1µm film thickness, J&W 438 
Scientific from Agilent). Helium at 145 kPa was used as the carrier gas. The GC oven 439 
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temperature program was 2min at 40°C followed by an increase at 4°C/min up to 260°C, where 440 
it was held for 10 min.  All data were collected and stored using Turbomax software (version 441 
3.5, Perkin Elmer). Compounds were identified from their mass spectra and identities 442 
confirmed by comparison of retention time (linear retention index, LRI) and mass spectra with 443 
those of authentic compounds analysed in online library database. Analyses were carried out 444 
using Agilent 6890/5975 GC-MS system (Agilent Technologies, Palo Alto, CA, USA) fitted 445 
with a Turbomatrix ATD.  446 
Indole, p-cresol and phenol (Sigma-Aldrich, Poole, UK) were diluted using the same internal 447 
standard which was 1, 2 dichlorobenzene in methanol (653ng/µL). Quantification of the 448 
samples was obtained through calibration curves of phenol, p-cresol, indole and skatole in 449 
concentrations between 25 and 100 µg/ml. 450 
 451 
Ammonia Analysis 452 
Samples at 0, 10 and 24 hours were diluted 1 in 50 v/v prior to analysis. Ammonia concentration 453 
of diluted fermentation samples was analysed using a FluoroSELECT™ ammonia kit (Sigma-454 
Aldrich, Poole, UK). Reagent was prepared by combining 100 μL assay buffer, 4 μL reagent A 455 
and 4 μL reagent B in the kit. 10 μL H2O (blank) and 10 μL sample was added to each glass 456 
vial. Afterwards, 100 μL reagent was added to each tube. Samples were kept in the dark for 15 457 
minutes at room temperature before they were read in the fluorometer. Ammonia standards 458 
were prepared by diluting 20 mmol/L NH4Cl in distilled water and the concentration range was 459 
0.25-1 mmol/L).  460 
Statistical analysis 461 
All statistical tests were performed with the use of IBM SPSS Statistics version 24 (IBM Corp, 462 
US). Results are presented as means ± SD. Changes in specific bacterial groups, organic acids, 463 
and ammonia were assessed among different treatments and time points using two-way 464 
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ANOVA. Significant differences were assessed by post hoc Tukey HSD test. In addition, to 465 
monitor the influence of protein and prebiotics independent t tests were used for all variables. 466 
For branched chain fatty acid and ammonia, two-way ANOVA was used to assess treatment 467 
effect and donor difference.  468 
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 637 
Figure 1 Bacterial counts as log10 CFU/mL in the single stage batch culture as analysed by FISH. Values are mean values at 24 and 48 hours 638 
fermentation from 3 omnivores’ microbiota ± standard deviation. a: * Mean values were significantly different between control and protein without 639 
Synergy1 (p<0.05). ** Mean values were significantly different between control and protein without Synergy1 (p<0.01). b: # Mean values were 640 
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significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different between protein with and 641 
without Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 (p<0.001). 642 
 643 
 644 
 645 
Figure 2 Bacterial counts as log10 CFU/mL in the single stage batch culture as analysed by FISH. Values are mean values at 24 and 48 hours 646 
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fermentation from 3 vegetarians’ microbiota ± standard deviation. * Mean values were significantly different between control and protein without 647 
Synergy1 (p<0.05). ** Mean values were significantly different between control and protein without Synergy1 (p<0.01). # Mean values were 648 
significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different between protein with and 649 
without Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 (p<0.001). 650 
 651 
 652 
 653 
 654 
 655 
 656 
34 
 
 657 
Figure 3 SCFA differences between sample with and without protein as mM in the single stage batch culture. Values are mean values at 24 and 48 658 
hours fermentation from 3 omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. * Mean values were significantly different 659 
between control and protein without Synergy1 (p<0.05). ** Mean values were significantly different between control and protein without Synergy1 660 
(p<0.01). *** Mean values were significantly different between control and protein without Synergy1 (p<0.001). # Mean values were significantly 661 
different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different between protein with and without 662 
Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 (p<0.001). 663 
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 664 
Figure 4 BCFA and valerate differences between sample with and without protein as mM in the single stage batch culture. Values are mean values 665 
at 24 and 48 hours fermentation from 3 omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. * Mean values were significantly 666 
different between control and protein without Synergy1 (p<0.05). ** Mean values were significantly different between control and protein without 667 
Synergy1 (p<0.01). *** Mean values were significantly different between control and protein without Synergy1 (p<0.001). # Mean values were 668 
significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different between protein with and 669 
without Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 (p<0.001). 670 
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 671 
Figure 5 Lactate and succinate differences between sample with and without protein as mM in the single stage batch culture. Values are mean 672 
values at 24 and 48 hours fermentation unless specified from 3 omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. a: * 673 
Mean values were significantly different between control and protein without Synergy1 (p<0.05). ** Mean values were significantly different 674 
between control and protein without Synergy1 (p<0.01). *** Mean values were significantly different between control and protein without 675 
Synergy1 (p<0.001). b: # Mean values were significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were 676 
significantly different between protein with and without Synergy1 (p<0.01). ### Mean values were significantly different between protein with 677 
and without Synergy1 (p<0.001). 678 
 679 
 680 
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 681 
 682 
 Figure   Changes in ammonia concentration 683 
(mM) of batch culture sample over time. Values are mean values at three time points from 3 omnivore and 3 vegetarian faecal donor’s ± standard 684 
deviation. * Mean values were significantly different from 0 hour fermentation samples (p<0.05). 685 
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 689 
 690 
 691 
 692 
 693 
 694 
 695 
 696 
 697 
 698 
 
Omnivores Vegetarians 
 
Control Protein without 
Synergy1a 
Protein with 
Synergy1b 
Control Protein without 
Synergy1a 
Protein with 
Synergy1b 
 
n=6 n=12 n=12 n=6 n=12 n=12 
Ammonia 
in mM 
23.07±9.58 165.24±77.44*** 91.16±33.24** 32.02±8.97 153.53±62.69*** 126.64±35.76 
39 
 
Table 1 Ammonia concentration in samples as mM in the single stage batch culture. Values are mean values at 24 hours fermentation from 3 699 
omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. a: *** Mean values were significantly different between control and 700 
protein without Synergy1 (p<0.001). b: ** Mean values were significantly different between protein with and without Synergy1 (p<0.01).  701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
 711 
 712 
 713 
 In vitro fermentation dosage 
40 
 
Dietary protein 2.4g 
Mucin 0.57g 
Digestive enzymes 0.18g 
Note: digestive enzyme is a mixture of 0.107g pepsin, 0.022g pancreatin, and 0.00079g α-
amylase based on an in vitro upper gut digestion simulation paper (56) 
Table 2 Endogenous and exogenous protein dosage to simulate the in vivo effect of 105g dietary protein per day consumption for 150ml batch 714 
culture experiment.  715 
 716 
 717 
 718 
 719 
 720 
 721 
 722 
 723 
 724 
41 
 
 725 
 726 
 727 
 728 
 729 
 730 
 731 
 732 
Protein Protein content Protein dose 
Casein 68.75% 3.5g 
Soy protein 75% 3.2g 
Meat extract 76% 3.2g 
Mycoprotein 64.2% 3.7g 
Table 3 Protein dose that is equivalent to 2.4g dietary protein responding with protein content 733 
 734 
 735 
42 
 
Table 4 Name, sequence, and target group of oligonucleotide probes used in this study for FISH of bacterial enumeration  736 
 
Probe 
name 
 
Sequence (5’ to 3’) 
 
Target groups 
 
References 
Non Eub ACTCCTACGGGAGGCAG
C 
Control probe complementary to EUB338  (57) 
Eub338 GCTGCCTCCCGTAGGAG
T 
Most Bacteria (58) 
Eub338II GCAGCCACCCGTAGGTG
T 
Planctomycetales (59) 
Eub338II
I 
GCTGCCACCCGTAGGTG
T 
Verrucomicrobiales (59) 
Bif164 CATCCGGCATTACCACCC Bifidobacterium spp. (60) 
43 
 
Lab158 GGTATTAGCAYCTGTTTC
CA 
Lactobacillus and Enterococcus (61) 
Bac303 CCAATGTGGGGGACCTT Most Bacteroidaceae and Prevotellaceae, some 
Porphyromonadaceae 
(62) 
Erec482 GCTTCTTAGTCARGTACC
G 
Most of the Clostridium coccoides-Eubacterium rectale group 
(Clostridium cluster XIVa and XIVb) 
(63) 
Rrec584 TCAGACTTGCCGYACCG
C 
Roseburia genus (64) 
Ato291 GGTCGGTCTCTCAACCC Atopobium cluster (65) 
Prop853 ATTGCGTTAACTCCGGC
AC 
Clostridial cluster IX (64) 
Fprau65
5 
CGCCTACCTCTGCACTAC Feacalibacterium prausnitzii and relatives (66) 
44 
 
DSV687 TACGGATTTCACTCCT Desulfovibrio genus (67) 
Chis150 TTATGCGGTATTAATCTY
CCTTT 
Most of the Clostridium histolyticum group (Clostridium cluster I 
and II) 
(63) 
EC 1531 CAC CGT AGT GCC TCG 
TCA TCA 
Escherichia coli BJ4 (68) 
  737 
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 738 
 739 
 740 
